Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Showing 20 of 0 results

Not applicableLooking for participantsNCT06909253
What this trial is testing

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
AstraZeneca 50
Testing effectiveness (Phase 2)Study completedNCT03362190
What this trial is testing

ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Ophthotech Corporation 64
Testing effectiveness (Phase 2)Study completedNCT01859962
What this trial is testing

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Presidio Pharmaceuticals, Inc. 38
Not applicableEnded earlyNCT00146094
What this trial is testing

Bone Mineral Density (BMD) in HIV Infection

Who this might be right for
OsteopeniaOsteoporosis
University Hospital, Strasbourg, France 44
Testing effectiveness (Phase 2)Study completedNCT01026610
What this trial is testing

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Large-scale testing (Phase 3)Study completedNCT01579474
What this trial is testing

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Who this might be right for
Hepatitis C
Boehringer Ingelheim 131
Post-approval studies (Phase 4)Study completedNCT01736761
What this trial is testing

A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

Who this might be right for
HIV
St Stephens Aids Trust 36
Not applicableStudy completedNCT01704469
What this trial is testing

A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients

Who this might be right for
Cancer Patients
Yonsei University 80
Large-scale testing (Phase 3)Study completedNCT00299104
What this trial is testing

Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 755
Post-approval studies (Phase 4)Study completedNCT00928889
What this trial is testing

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 160
Post-approval studies (Phase 4)Study completedNCT02451137
What this trial is testing

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 3,304
Early research (Phase 1)Study completedNCT00777608
What this trial is testing

Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 106
Testing effectiveness (Phase 2)Study completedNCT00002225
What this trial is testing

Efavirenz in Combination With Stavudine and Didanosine

Who this might be right for
HIV Infections
Dupont Merck 60
Large-scale testing (Phase 3)Study completedNCT00621140
What this trial is testing

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 503
Testing effectiveness (Phase 2)Study completedNCT03020004
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 70
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Large-scale testing (Phase 3)Study completedNCT00808002
What this trial is testing

Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 30
Post-approval studies (Phase 4)Study completedNCT00389402
What this trial is testing

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 120
Testing effectiveness (Phase 2)Ended earlyNCT00144105
What this trial is testing

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Who this might be right for
HIV Infections
Boehringer Ingelheim 562
Post-approval studies (Phase 4)Study completedNCT00762892
What this trial is testing

Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients

Who this might be right for
HIV Infections
The University of Texas Health Science Center, Houston 33
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation